Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124203267 | 12420326 | 7 | F | 2016 | 20160805 | 20160531 | 20160805 | EXP | US-PFIZER INC-2016272556 | PFIZER | 71.00 | YR | M | Y | 86.00000 | KG | 20160805 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124203267 | 12420326 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75MG CAPSULE ONCE AT NIGHT | M22778 | 21446 | 75 | MG | CAPSULE, HARD | QD | |||||
| 124203267 | 12420326 | 2 | SS | LYRICA | PREGABALIN | 1 | 75MG CAPSULE TWICE A DAY, MORNING AND NIGHT | 21446 | 75 | MG | CAPSULE, HARD | BID | |||||||
| 124203267 | 12420326 | 3 | SS | LYRICA | PREGABALIN | 1 | 75 MG, UNK | 21446 | 75 | MG | CAPSULE, HARD | ||||||||
| 124203267 | 12420326 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG BID, AS NEEDED | 21446 | 150 | MG | CAPSULE, HARD | |||||||
| 124203267 | 12420326 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 124203267 | 12420326 | 6 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 124203267 | 12420326 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 3X/DAY | 20235 | 300 | MG | CAPSULE, HARD | TID | |||||||
| 124203267 | 12420326 | 8 | SS | GABAPENTIN. | GABAPENTIN | 1 | 20235 | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124203267 | 12420326 | 1 | Diabetic neuropathy |
| 124203267 | 12420326 | 2 | Neuropathy peripheral |
| 124203267 | 12420326 | 3 | Pain |
| 124203267 | 12420326 | 4 | Pain in extremity |
| 124203267 | 12420326 | 5 | Dysstasia |
| 124203267 | 12420326 | 6 | Neuralgia |
| 124203267 | 12420326 | 7 | Diabetic neuropathy |
| 124203267 | 12420326 | 8 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124203267 | 12420326 | OT |
| 124203267 | 12420326 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124203267 | 12420326 | Condition aggravated | |
| 124203267 | 12420326 | Drug dose omission | |
| 124203267 | 12420326 | Drug ineffective | |
| 124203267 | 12420326 | Drug ineffective for unapproved indication | |
| 124203267 | 12420326 | Insomnia | |
| 124203267 | 12420326 | Lung neoplasm malignant | |
| 124203267 | 12420326 | Neuropathy peripheral | |
| 124203267 | 12420326 | Product use issue | |
| 124203267 | 12420326 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124203267 | 12420326 | 3 | 201601 | 0 | ||
| 124203267 | 12420326 | 5 | 20160715 | 0 | ||
| 124203267 | 12420326 | 7 | 2008 | 0 |